Kunming Longjin Pharmaceutical Co., Ltd.

    Kunming Longjin Pharmaceutical Co., Ltd.

    SSZSE:002750
    0.59
    CNY
    0.00
    (0.00%)
    Kunming Longjin Pharmaceutical Co., Ltd.
    SZSE:002750
    (Shenzhen Stock Exchange)

    Recent

    price

    0.59

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2011
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    TTM
    CNY
    0.5
    0.61
    0.6
    0.62
    0.48
    0.56
    0.76
    0.84
    0.69
    0.63
    1.75
    0.31
    0.22
    - -
    0.11
    Revenue per Share
    0.23
    0.33
    0.25
    0.21
    0.16
    0.23
    0.09
    0.03
    -0.06
    0.03
    0.01
    -0.14
    -0.18
    - -
    -0.1
    Basic EPS, GAAP
    -0.06
    0.06
    0.16
    0.17
    0.12
    0.2
    0.1
    0.04
    -0.01
    -0.08
    -0.06
    -0.1
    -0.14
    - -
    -0.04
    Free Cash Flow per Basic Share
    - -
    - -
    0.2
    0.27
    0.13
    0.05
    0.15
    0.03
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    0.53
    0.65
    0.9
    0.84
    1.09
    1.57
    1.5
    1.5
    1.44
    1.46
    1.46
    1.33
    1.15
    - -
    1.04
    Book Value per Share
    0.55
    0.69
    0.94
    0.89
    1.54
    1.63
    1.57
    1.56
    1.53
    1.64
    1.57
    1.4
    1.2
    - -
    1.03
    Tangible Book Value per Share
    300
    300
    300
    300
    375
    401
    400
    401
    400
    400
    402
    401
    401
    - -
    400
    Basic Weighted Avg Shares
    149
    182
    179
    187
    181
    224
    304
    336
    275
    254
    703
    123
    87
    66
    46
    Sales/Revenue/Turnover
    51.19
    50
    48.02
    39.67
    33.87
    29.16
    11.72
    1.2
    0.47
    1.55
    -0.21
    -27.81
    -71.33
    -43.39
    -59.86
    Operating Margin (%)
    2
    2
    4
    22
    22
    22
    22
    23
    26
    28
    31
    30
    31
    17
    - -
    Depreciation Expense
    70
    100
    75
    64
    62
    91
    35
    14
    -23
    12
    3
    -56
    -71
    -41
    -41
    Net Income, GAAP
    14.69
    15.23
    16.4
    16
    14.98
    10.8
    13.83
    11.8
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    46.89
    55.01
    41.97
    33.92
    34.06
    40.71
    11.55
    4.13
    -8.39
    4.65
    0.44
    -45.64
    -81.9
    -62.34
    -89.21
    Profit Margin (%)
    18
    -6
    3
    11
    347
    388
    367
    373
    374
    419
    409
    383
    334
    290
    272
    Working Capital
    - -
    - -
    1
    - -
    - -
    - -
    - -
    - -
    - -
    1
    1
    1
    1
    2
    2
    LT Debt
    187
    227
    302
    286
    599
    670
    646
    656
    666
    705
    678
    605
    541
    494
    485
    Total Equity
    - -
    34.44
    26.37
    19.77
    11.26
    9.03
    4.59
    0.54
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    54.02
    32.35
    23.46
    18.02
    17.58
    5.6
    0.8
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    56.79
    32.49
    24.42
    18.73
    17.58
    5.73
    2.31
    -3.93
    2.03
    0.53
    -10.02
    -14.29
    -9.42
    -9.41
    Return on Common Equity (%)

    Capital Structure

    CNY

    •

    in mil. unless spec.
    Sep'24
    Dec'24
    Mar'25
    ST Debt
    1
    2
    1
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    2
    2
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    401
    401
    401
    Market Capitalization
    910
    878
    568

    Working Capital

    CNY

    •

    in mil. unless spec.
    Sep'24
    Dec'24
    Mar'25
    Total Current Assets
    355
    338
    311
    Cash, Cash Equivalents & STI
    303
    295
    270
    Accounts Receivable, Net
    12
    9
    7
    Inventories
    31
    22
    25
    Total Current Liabilities
    42
    49
    39
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    1
    2
    1
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    CNY

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    9.32%
    -5.59%
    -8.67%
    Free Cash Flow
    79.88%
    192.7%
    -18.19%
    Net Income, GAAP
    -249.82%
    -430.83%
    -41.58%
    Sales/Revenue/Turnover
    8.2%
    6.7%
    -23.25%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    22
    22
    27
    16
    87
    2024
    26
    13
    7
    20
    66
    2025
    6
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    -0.02
    - -
    - -
    - -
    -0.18
    2024
    -0.01
    - -
    - -
    - -
    - -
    2025
    -0.01
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business